Brief: NextCell Applies For Prediction Methodology Patent
03/07/2018 07:38
July 3 (Reuters) - NEXTCELL PHARMA AB NXTCL.TE :
* NEXTCELL APPLIES FOR PREDICTION METHODOLOGY PATENT
* APPLICATION ON A METHOD FOR PREDICTING IF A PATIENT IS
SUSCEPTIBLE TO TREATMENT WITH PROTRANS
Source text for Eikon: ID:nWkr5psZq2
Further company coverage: NXTCL.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln